Females Suffer From Gender Gap in Cancer Trials, Drug Development

Teacher works to spread the word about Crohn’s disease
September 8, 2016
Hospital, hepatitis C outbreak victims reach settlement 
September 8, 2016
Show all

Females Suffer From Gender Gap in Cancer Trials, Drug Development

There is a gender gap in cancer research.

Identifying effective cancer treatments is never an easy process, and even drugs that make it to the market are rarely effective on every patient. As cancer treatment becomes more personalized, clinicians have come to realize how biological factors beyond a patient’s control—especially gender—can determine treatment outcome. Oncologists often know a treatment may fail, not based on mountains of study, but through their own frustration that comes from treating patients.

This is because studies on blockbuster cancer drugs rarely reflect the population of patients who fall ill with the disease they seek to cure. This is a challenge for many patient populations but an overwhelming amount of research shows females suffer unjustly from clinical trial inequality.

“Except for the cancers for male patients and female patients—prostate cancer is obviously all male and breast cancer is predominantly female—we don’t pay that much attention to the gender of our models or how that would affect treatment outcomes,” says Dr. Faye Johnson of the University of Texas MD Anderson Cancer Center. “ But research suggests that we really should.”

Read Full Article: Females Suffer From Gender Gap in Cancer Trials, Drug Development

Read Full Article: Females Suffer From Gender Gap in Cancer Trials, Drug Development

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.